High Dose Haloperidol for Delirium in HIVAssociated Dementia
Journal: Journal of HIV and AIDS (Vol.3, No. 2)Publication Date: 2017-05-04
Authors : Nicole M Bohm Madelyne Ann C Bean Ryan P Medved Meghan May Shannon Drayton M Sean Boger;
Page : 1-5
Keywords : Antipsychotics; Delirium; HIV-Associated Neurologic Disorder (HAND); Dementia;
Abstract
The limited evidence available has suggested that patients with HIV–associated dementia respond clinically to low doses of antipsychotics and may be more prone to experience side effects at typically used doses. In this case, a 30-year-old female with untreated HIV/AIDS was admitted for aggressive behaviors refractory to low doses of multiple agents. However, she responded without adverse events to higher doses of haloperidol in conjunction with lorazepam in the setting of newly initiated combination antiretroviral therapy. A review of the relevant literature and discussion follows a description of this patient's hospital course.
Other Latest Articles
- Use of External Jugular Vein Puncture Technique in Ambulatory Settings for HCV or HIV/HCV Coinfected People Who Inject Drugs
- Toward a Pan-African HIV Vaccine Development Agenda
- CD4 Counts in Capillary and Venous Blood Samples
- Assessment of Integrated Counselling and Testing Centers (ICTC) in Chhattisgarh, India
- Elimination of Mother-to-Child Transmission of HIV, an experience from Oman
Last modified: 2020-08-10 21:09:19